KARYOPHARM Trademark

Trademark Overview

On Friday, June 4, 2021, a trademark application was filed for KARYOPHARM with the United States Patent and Trademark Office. The USPTO has given the KARYOPHARM trademark a serial number of 90755312. The federal status of this trademark filing is REGISTERED as of Tuesday, June 18, 2024. This trademark is owned by Karyopharm Therapeutics Inc.. The KARYOPHARM trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals for treatment of life threatening diseases; pharmaceuticals for treatment of cancer
karyopharm

General Information

Serial Number90755312
Word MarkKARYOPHARM
Filing DateFriday, June 4, 2021
Status700 - REGISTERED
Status DateTuesday, June 18, 2024
Registration Number7422474
Registration DateTuesday, June 18, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 11, 2023

Trademark Statements

Goods and Servicespharmaceuticals for treatment of life threatening diseases; pharmaceuticals for treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 26, 2021
Primary Code005
First Use Anywhere DateWednesday, November 12, 2014
First Use In Commerce DateWednesday, November 12, 2014

Trademark Owner History

Party NameKARYOPHARM THERAPEUTICS INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressNEWTON, MA 02459
Party NameWILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL TRUSTEE
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressWILMINGTON, DE 19801
Party NameKaryopharm Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNewton, MA 02459
Party NameKaryopharm Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewton, MA 02459
Party NameKaryopharm Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewton, MA 02459

Trademark Events

Event DateEvent Description
Tuesday, June 8, 2021NEW APPLICATION ENTERED
Thursday, August 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 21, 2022ASSIGNED TO EXAMINER
Saturday, February 26, 2022NON-FINAL ACTION WRITTEN
Saturday, February 26, 2022NON-FINAL ACTION E-MAILED
Saturday, February 26, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 25, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 25, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 25, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 6, 2022FINAL REFUSAL WRITTEN
Tuesday, September 6, 2022FINAL REFUSAL E-MAILED
Tuesday, September 6, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, March 6, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, March 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 11, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 11, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 6, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 6, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 6, 2023SOU EXTENSION 1 FILED
Wednesday, December 6, 2023SOU EXTENSION 1 GRANTED
Friday, December 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 15, 2023TEAS STATEMENT OF USE RECEIVED
Saturday, January 6, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 15, 2023USE AMENDMENT FILED
Saturday, January 6, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, January 15, 2024SU - NON-FINAL ACTION - WRITTEN
Monday, January 15, 2024NON-FINAL ACTION E-MAILED
Monday, January 15, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, May 12, 2024SU-EXAMINER'S AMENDMENT WRITTEN
Sunday, May 12, 2024EXAMINERS AMENDMENT E-MAILED
Sunday, May 12, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sunday, May 12, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, May 14, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 14, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 18, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, June 18, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, October 16, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, December 8, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, December 8, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, December 12, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, December 12, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Related Keywords

karyopharm pharmaceuticals treatment cancer diseases life threatening